CLINICAL CHARACTERISTICS AND FIB-4 RISK STRATIFICATION OF PRIMARY CARE PATIENTS WITH OBESITY, DIABETES, OR BOTH: REAL-WORLD IMPLICATIONS FOR ADOPTING A FIB-4 REFERRAL ALGORITHM TO DETECT METABOLIC DYSFUNCTION-ASSOCIATION STEATOTIC LIVER DISEASE (MASLD) WITH ADVANCED FIBROSIS

被引：0
|
作者：
Chu, Janet [1 ]
Khalili, Mandana [1 ]
Goldman, Max [2 ]
Hameed, Bilal [1 ]
Ha, Nghiem [1 ]
Fox, Rena [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Kaiser Permanente San Francisco Med Ctr, San Francisco, CA USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1141
引用
收藏
页码：S868 / S869
页数：2
相关论文
共 24 条
  • [1] Limitations of FIB-4 Score in Excluding Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Bentley, Blake
    Ventura, Frank
    Obermmiller, Corey
    Russo, Mark
    Rudnick, Sean
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1380 - S1380
  • [2] DISCORDANCE OF FIB-4 AND SAFE SCORES FOR THE PREDICTION OF ADVANCED FIBROSIS IN PRIMARY CARE PATIENTS WITH OBESITY, DIABETES, OR BOTH
    Chu, Janet
    Ha, Nghiem
    Khalili, Mandana
    Goldman, Max
    Hameed, Bilal
    Fox, Rena
    HEPATOLOGY, 2024, 80 : S876 - S877
  • [3] CLINICAL MANAGEMENT OF DISCREPANCIES BETWEEN FIB-4 AND LIVER STIFFNESS MEASUREMENT IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Rabbat, Joseph
    Lee, Hye Won
    Yip, Terry Cheuk-Fung
    Lin, Huapeng
    Tsochatzis, Emmanuel
    Petta, Salvatore
    Bugianesi, Elisabetta
    Yoneda, Masato
    Zheng, Ming-Hua
    Hagstrom, Hannes
    Boursier, Jerome
    Calleja, Jose Luis
    Goh, George Boon-Bee
    Chan, Wah Kheong
    Gallego-Duran, Rocio
    Sanyal, Arun
    de Ledinghen, Victor
    Newsome, Philip
    Fan, Jian-Gao
    Castera, Laurent
    Lai, Michelle
    Fournier, Celine
    Wong, Grace
    Pennisi, Grazia
    Armandi, Angelo
    Nakajima, Atsushi
    Liu, Wen-Yue
    Shang, Ying
    Saint Loup, Marc De
    Llop, Elba
    Teh, Kevin
    Romero, Carmen Lara
    Asgharpour, Amon
    Mahgoub, Sara
    Chan, Mandy
    Canivet, Clemence
    Romero-Gomez, Manuel
    Kim, Seung Up
    HEPATOLOGY, 2024, 80 : S566 - S567
  • [4] FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
    Avares-da-Silva, Mario Reis
    Vargas, Marcia da Silva
    Rabie, Soheyla Mohd Souza
    Jonko, Gabriella
    Riedel, Patricia Gabriela
    Longo, Larisse
    Goncalves, Marcelo Rodrigues
    Luft, Vivian Cristine
    Joveleviths, Dvora
    ANNALS OF HEPATOLOGY, 2025, 30 (01)
  • [5] Diagnostic performances of FIB-4 and NFS in metabolic dysfunction-associated steatotic liver disease in primary care clinic of Asia
    Yoon, Eileen
    An, Jihyun
    Il Kim, Ha
    Sohn, Joo Hyun
    Kang, Bo-Kyeong
    Jang, Eun Chul
    Park, Huiyul
    Kim, Hye-Lin
    Ahn, Sang Bong
    Oh, Joo Hyun
    Lee, Hyo Young
    Jun, Dae Won
    JOURNAL OF HEPATOLOGY, 2024, 80 : S553 - S553
  • [6] Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kang, Yeo-Wool
    Baek, Yang-Hyun
    Moon, Sang-Yi
    DIAGNOSTICS, 2024, 14 (22)
  • [7] ASSOCIATION BETWEEN US ABDOMEN, FIB-4, AND VCTE DETERMINED STEATOSIS AND DISEASE SEVERITY IN A CANADIAN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) COHORT
    Bera, Chinmay
    Hamdan, Nashla
    Kosick, Heather
    Allam, Nader
    Fakhriyehasl, Mina
    Jhaveri, Kartik
    Patel, Keyur
    HEPATOLOGY, 2024, 80 : S451 - S451
  • [8] Effects of SGLT2i and Pioglitazone on FIB-4 Index in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)-A Real World Retrospective Study from India
    Padhye, Dakshata
    Seshadri, Krishna
    DIABETES, 2024, 73
  • [9] Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes
    Andrew D. Schreiner
    Jingwen Zhang
    William P. Moran
    David G. Koch
    Sherry Livingston
    Chloe Bays
    Justin Marsden
    Patrick D. Mauldin
    Mulugeta Gebregziabher
    Journal of General Internal Medicine, 2023, 38 : 2453 - 2460
  • [10] Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes
    Schreiner, Andrew D.
    Zhang, Jingwen
    Moran, William P.
    Koch, David G.
    Livingston, Sherry
    Bays, Chloe
    Marsden, Justin
    Mauldin, Patrick D.
    Gebregziabher, Mulugeta
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (11) : 2453 - 2460
123